Physician profile
Jonathan Pire
NPI 1942845722
$2,590.32
in general payments reported to CMS, 2019-2025
14 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $437 · 2021: $274 · 2022: $498 · 2023: $387 · 2024: $556 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $415.35 | 2020-2024 | Na |
| Depuy Synthes Sales INC. | $405.66 | 2020-2025 | Na |
| Kerecis Limited | $321.14 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Axogen | $286.85 | 2022-2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Peerless Surgical INC. | $263.26 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $149.41 | 2021 | |
| Treace Medical Concepts, INC. | $139.24 | 2024 | |
| Orthopediatrics Corp. | $138.85 | 2025 | |
| Skeletal Dynamics INC | $133.12 | 2023 | Align, Implate, Geminus |
| Alafair Biosciences, INC. | $119.02 | 2023 | Versawrap |
| Si-Bone, INC. | $97.23 | 2022 | |
| Providence Medical Technology, INC. | $86.73 | 2024 | |
| Biomarin Pharmaceutical INC. | $17.26 | 2020 | |
| Vericel Corporation | $17.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Pire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.